Axsome Therapeutics (AXSM) Net Income towards Common Stockholders Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -10.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 26.38% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -46.86% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 34.98% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 47.10% |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | -79.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -79.08% |
| Dec 31, 2025 | 22.43% |
| Sep 30, 2025 | -1.76% |
| Jun 30, 2025 | -4.97% |
| Mar 31, 2025 | -14.45% |
| Dec 31, 2024 | -30.15% |
| Sep 30, 2024 | -22.80% |
| Jun 30, 2024 | -34.95% |
| Mar 31, 2024 | -32.69% |
| Dec 31, 2023 | -50.02% |
| Sep 30, 2023 | -42.10% |
| Jun 30, 2023 | -54.19% |
| Mar 31, 2023 | 29.80% |
| Dec 31, 2022 | -35.15% |
| Sep 30, 2022 | -32.49% |
| Jun 30, 2022 | -44.40% |
| Mar 31, 2022 | -55.01% |
| Dec 31, 2021 | -78.55% |
| Sep 30, 2021 | -61.40% |
| Jun 30, 2021 | -57.38% |
| Mar 31, 2021 | -57.57% |
| Dec 31, 2020 | -89.33% |
| Sep 30, 2020 | -76.71% |
| Jun 30, 2020 | -69.34% |
| Mar 31, 2020 | -85.86% |
| Dec 31, 2019 | -74.69% |
| Sep 30, 2019 | -67.14% |
| Jun 30, 2019 | -58.89% |
| Mar 31, 2019 | -56.10% |
| Dec 31, 2018 | 44.68% |
| Sep 30, 2018 | -89.06% |
| Jun 30, 2018 | -85.86% |
| Mar 31, 2018 | -83.16% |